Daron Evans, President & Chief Executive Officer
Mr. Evans joined the company as President and CEO in April 2015, and has served on Nephros’ board of directors since 2013. He is a life sciences executive with over 20 years of financial leadership and operational experience. Mr. Evans was recently Managing Director of PoC Capital, LLC, and is a member of the board of Zumbro Discovery, Inc., an early stage company developing a novel therapy for resistant hypertension. From 2007 to 2013, Mr. Evans was Chief Financial Officer of Nile Therapeutics, Inc., a development-stage cardiovascular company that merged with Capricor Therapeutics, Inc. (NASDAQ:CAPR) in 2013. From 2004 to 2007, he held various project management and performance improvement roles at Vistakon Inc. and Scios, Inc., both divisions of Johnson & Johnson Corp. Mr. Evans was a co-founder of Applied Neuronal Network Dynamics, Inc. and served as its President from 2002 to 2004. From 1995 to 2002, Mr. Evans served in various roles at consulting firms Arthur D. Little and Booz Allen & Hamilton. Mr. Evans received his Bachelor of Science in Chemical Engineering from Rice University, his Master of Science in Biomedical Engineering from a joint program at the University of Texas at Arlington and Southwestern Medical School and his MBA from the Fuqua School of Business at Duke University.
Andy Astor, Chief Operating & Financial Officer
Andy Astor is a technology and business executive with 30 years of financial and operating experience. Mr. Astor was most recently President and Chief Financial Officer at Open Source Consulting Group, a growth stage services firm. Previously, he was a Managing Director at Synechron, a global consulting organization, from 2013 to 2015. From 2009 to 2013, he served as Vice President at Asurion, a large, privately held insurance company. Mr. Astor was co-founder of the software company EnterpriseDB, and served as its CEO from 2004 to 2008. Mr. Astor was Vice President, Strategic Solutions at webMethods (ETR: SOW), a software firm, from 2002 to 2004. Mr. Astor was Vice President of Transactional Products at Dun & Bradstreet (NYSE: DNB) from 1998 to 2001. Prior to 1998, Mr. Astor held various roles at American Management Systems, SHL/MCI Systemhouse, and Ernst & Young. Mr. Astor received his Bachelor of Arts in Mathematics from Clark University, and his MBA from The Wharton School at the University of Pennsylvania.
Monet Carnahan, Vice President, Dialysis Products
Mrs. Carnahan joined the company as Director of Dialysis Products in August of 2015. She is a Registered Nurse with over 10 years of nursing experience in Nephrology and is a subject matter expert in chronic kidney disease, transplantation, vascular access, and end stage renal disease with both in-center and home therapy. Mrs. Carnahan was previously the Program Manager of Renal Care Coordinators with Fresenius Medical Care (FMC). At FMC managed National Accounts and Employees across the United States, and worked with specific dialysis clinics to identify needs, develop and implement algorithms to improve patient outcomes. Mrs. Carnahan has experience with critical care where she started her career at the Tennessee Valley Health Care System in Nashville, TN. Mrs. Carnahan received her Nursing Degree from Motlow State. She was recently a member of a CMS Technical Expert Panel for Vascular Access, and currently reviews publications for ANNA journals, educational textbooks, and modules.
Greg Lucas, President, Aether Water Systems
Mr. Lucas is the founder (2011) and President of Aether Water Systems, acquired by Nephros in 2018. Aether designs and develops water filtration systems, including new product development, OEM/ODM design, and repetitive and process manufacturing. Prior to founding Aether, Mr. Lucas was founder and President of Water Logic Systems, which designed and developed reverse osmosis systems for industrial and commercial applications. Mr. Lucas’ career experience includes global distribution and procurement sourcing, production manufacturing systems, and RO system development. He holds various certifications for water filtration design and development.
Michael Milman, Vice President, Research & Development
Mr. Milman has over 15 years experience bringing new products to market in electronics and medical devices industries. Mr. Milman focuses on the development and commercialization of medical and commercial products, and runs Nephros Product Development Program. Prior to Nephros, Mr. Milman held several positions at Stryker bringing new products through manufacturing to market, innovating coating applications, and research and development of custom implant products. Mr. Milman holds a B.S. in Mechanical Engineering from Lehigh University and several advanced engineering certifications.
Kimothy Smith, Vice President, Pathogen Detection Systems
Dr. Kimothy Smith has extensive experience working internationally, establishing relationships, collaboratively conducting research programs, and building health-related infrastructures and the local capability and capacity to support them. Prior to joining Nephros, Inc., Dr. Smith was the Chief Operating Officer, Senior Consultant, and co-founder of McCarthy & Smith Consulting, LLC, and Neviathan, LLC, where he provided professional consulting services in the areas of biosurveillance, bioforensics, biodefense, biosecurity, molecular genetics and diagnostics, and food safety, defense, and security. Dr. Smith serves as the Director of Scientific Affairs for LexaGene Corporation, has served as the Chief Science Officer for ExcitePCR Corporation, and the Chief Technology Advisor on the Board of Advisors for PositiveID Corporation. He has served as a Professor of Advanced Analytics and the Senior Director for the Applied Innovation Center for Advanced Analytics at the Desert Research Institute. Dr. Smith has also served as a Professor of Microbiology and Epidemiology for the University of Nevada School of Community Health Sciences. Dr. Smith earned a PhD in molecular epidemiology from Louisiana State University (1999) where he was curator of the Worldwide Bacillus anthracis collection. He earned his BS in Biochemistry and Doctorate of Veterinary Medicine from Oklahoma State University and was a practicing veterinarian for nearly 10 years.
Shane Sullivan, Vice President, Sales
Mr. Sullivan has spent nearly two decades in sales leadership roles in the healthcare, life science and biopharmaceutical industry. He brings industry experience, an extensive professional network and strong customer focus to our team at Nephros. Prior to joining Nephros, he led the sales team at Saxton Bradley with a focus on the healthcare and scientific market. Before Saxton Bradley, Mr. Sullivan was the Western Regional Sales Manager at Thermo Scientific (NYSE:TMO). While there, he lead the $175 million laboratory furnishings and airflow products division to ten consecutive double digit increases in the Western Region. His extensive work within the architectural design, engineering, specifying, and contracting communities significantly contributed to their sales on a national level. Prior to Thermo, Mr. Sullivan worked at Applied Instruments, where he represented a variety of equipment manufacturers focused on solutions for the healthcare, life science and bio pharmaceutical research markets. At Applied Instruments, he helped grow their business, establish stronger roots for their organization in the region and developed a strong understanding of the distribution market. Prior, at MDT Castle, he led the launch and direct sales efforts of their life science and pharmaceutical sterilization business. His sales efforts ultimately contributed to the merger that formed Getinge-Castle. Mr. Sullivan earned his undergraduate degree in Business Administration from the University of Southern California.
Vashone Thomas, Vice President, Quality & Regulatory
With over 10 years’ experience in the medical device, laboratory, and scientific product industries, Mrs. Vashone R. Thomas joined Nephros in January of 2018, as the Director of Quality Assurance and Regulatory Affairs. As the Director of Quality Assurance and Regulatory Affairs, Mrs. Thomas is responsible for leading and strategically directing the organization in matters surrounding Quality and Regulatory, and is accountable for the design, development, execution and administration of the QMS in meeting all compliance requirements nationally and globally. Prior to Nephros, Mrs. Thomas has successfully implemented and maintained ISO13485, QMS, 510(K) and product submissions, for Integrated Dental Systems, as well as, implemented and maintained ISO9001 and ISO17025 compliance at Applied DNA Sciences. Mrs. Thomas holds a Master of Science degree from Pace University, a Bachelor of Arts from the University at Buffalo and is a Lead ISO13485 Certified Auditor.